GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 2 filers reported holding GEMINI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $647,000 | -3.3% | 394,578 | -0.3% | 0.00% | – |
| Q2 2022 | $669,000 | +21.4% | 395,684 | -0.4% | 0.00% | – |
| Q1 2022 | $551,000 | -90.0% | 397,346 | -78.9% | 0.00% | – |
| Q4 2021 | $5,492,000 | -28.2% | 1,887,241 | -0.3% | 0.00% | -100.0% |
| Q3 2021 | $7,649,000 | -59.3% | 1,893,300 | -34.8% | 0.00% | 0.0% |
| Q2 2021 | $18,801,000 | -47.9% | 2,905,800 | +4.2% | 0.00% | -66.7% |
| Q1 2021 | $36,104,000 | – | 2,789,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 2,435,125 | $9,838,000 | 3.06% |
| Asymmetry Capital Management, L.P. | 284,079 | $1,148,000 | 0.69% |
| Orbimed Advisors | 5,826,224 | $23,538,000 | 0.26% |
| Boxer Capital, LLC | 1,300,000 | $5,252,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,137,823 | $8,637,000 | 0.15% |
| Ikarian Capital, LLC | 421,050 | $1,701,000 | 0.12% |
| JS Capital Management LLC | 474,457 | $1,917,000 | 0.11% |
| PURA VIDA INVESTMENTS, LLC | 494,400 | $1,997,000 | 0.06% |
| HARVARD MANAGEMENT CO INC | 250,000 | $1,010,000 | 0.06% |
| Atom Investors LP | 102,792 | $415,000 | 0.03% |